{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000343.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000343.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "p.A53T missense variant associated with early-onset Parkinson's disease"
        }
      ]
    },
    {
      "Gene": "MAPT",
      "variants": [
        {
          "HGVS": "NM_001130805.3:c.1664_1665del",
          "cDNA Change": {
            "transcript": "NM_001130805.3",
            "ref": "GT",
            "alt": "del",
            "position": "1664-1665"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "fs",
            "position": "556"
          },
          "Description in input context": "p.Glu556fs frameshift mutation associated with Alzheimer's disease"
        }
      ]
    },
    {
      "Gene": "APOE",
      "variants": [
        {
          "HGVS": "NM_000041.2:c.388G>A",
          "cDNA Change": {
            "transcript": "NM_000041.2",
            "ref": "G",
            "alt": "A",
            "position": "388"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "130"
          },
          "Description in input context": "APOE ε4 allele (c.388G>A, p.E130D) associated with Alzheimer's disease progression"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015377.3:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_015377.3",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S loss-of-function mutation associated with Parkinson's disease"
        }
      ]
    },
    {
      "Gene": "PSEN1",
      "variants": [
        {
          "HGVS": "NM_000279.2:c.1478G>A",
          "cDNA Change": {
            "transcript": "NM_000279.2",
            "ref": "G",
            "alt": "A",
            "position": "1478"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Ter",
            "position": "493"
          },
          "Description in input context": "p.Arg493Ter nonsense mutation in early-onset Alzheimer's disease"
        }
      ]
    },
    {
      "Gene": "PRNP",
      "variants": [
        {
          "HGVS": "NM_000273.2:c.532G>A",
          "cDNA Change": {
            "transcript": "NM_000273.2",
            "ref": "G",
            "alt": "A",
            "position": "532"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "N",
            "position": "178"
          },
          "Description in input context": "p.D178N missense mutation associated with Creutzfeldt-Jakob disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Parkinson's disease": "MONDO:0005080",
    "Alzheimer's disease": "MONDO:0005081",
    "Early-onset Alzheimer's disease": "MONDO:0010873",
    "Creutzfeldt-Jakob disease": "MONDO:0003607"
  },
  "Experiment Method": {
    "2008 SNCA study": {
      "Method": "Western blot, immunohistochemistry",
      "Readout description": [
        {
          "Variant": "NM_000343.2:c.158C>T",
          "Conclusion": "Increased α-synuclein aggregation in neuronal cells",
          "Molecular effect": "Enhanced protein misfolding and neurotoxicity"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    },
    "2012 MAPT study": {
      "Method": "PCR, Sanger sequencing",
      "Readout description": [
        {
          "Variant": "NM_001130805.3:c.1664_1665del",
          "Conclusion": "Altered tau protein phosphorylation and aggregation",
          "Molecular effect": "Increased neurofibrillary tangle formation"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    },
    "2015 APOE study": {
      "Method": "Genotyping, longitudinal cohort analysis",
      "Readout description": [
        {
          "Variant": "NM_000041.2:c.388G>A",
          "Conclusion": "Accelerated amyloid-β plaque accumulation",
          "Molecular effect": "Reduced lipid binding and clearance of amyloid-β"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    },
    "2018 LRRK2 study": {
      "Method": "Kinase activity assays, cell culture",
      "Readout description": [
        {
          "Variant": "NM_015377.3:c.6056G>A",
          "Conclusion": "Reduced LRRK2 kinase activity in fibroblasts",
          "Molecular effect": "Impaired autophagy and mitochondrial function"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    },
    "2020 PSEN1 study": {
      "Method": "Genomic sequencing, functional assays",
      "Readout description": [
        {
          "Variant": "NM_000279.2:c.1478G>A",
          "Conclusion": "Premature termination of PSEN1 protein",
          "Molecular effect": "Disrupted γ-secretase complex and amyloid-β processing"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    },
    "2023 PRNP study": {
      "Method": "PRNP expression analysis, prion propagation assays",
      "Readout description": [
        {
          "Variant": "NM_000273.2:c.532G>A",
          "Conclusion": "Increased prion protein misfolding and propagation",
          "Molecular effect": "Enhanced susceptibility to prion disease"
        }
      ],
      "Controls": "N.D.",
      "Approved assay": "Yes"
    }
  }
}